Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthew Buerger"'
Autor:
Peter B. Rupert, Matthew Buerger, Emily J. Girard, Marie Frutoso, Don Parrilla, Kevin Ng, Theodore Gooley, Veronika Groh, Roland K. Strong
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e28583- (2024)
NKG2D and its ligands are critical regulators of protective immune responses controlling infections and cancer, defining a crucial immune signaling axis. Current therapeutic efforts targeting this axis almost exclusively aim at enhancing NKG2D-mediat
Externí odkaz:
https://doaj.org/article/ff64ffa78a71418689ec662a6f844c00
Autor:
Kathryn A. K. Finton, Peter B. Rupert, Della J. Friend, Ana Dinca, Erica S. Lovelace, Matthew Buerger, Domnita V. Rusnac, Ulysses Foote-McNabb, William Chour, James R. Heath, Jean S. Campbell, Robert H. Pierce, Roland K. Strong
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
MHC class I “single-chain trimer” molecules, coupling MHC heavy chain, β2-microglobulin, and a specific peptide into a single polypeptide chain, are widely used in research. To more fully understand caveats associated with this design that may a
Externí odkaz:
https://doaj.org/article/738bbd7365bf4134a8132bf3cd7b009a
Autor:
Peter B. Rupert, Meei-Li Huang, Haiying Zhu, Andrew Fiore-Gartland, Arnold Park, Colleen McLaughlin, Chance Brock, April K. Randhawa, Roland K. Strong, Maurine D. Miner, Yixuan J. Hou, Matthew Buerger, Ralph S. Baric, Emily S Ford, Leonidas Stamatatos, Anton M Sholukh, Hannah Kaiser, Russell St Germain, Florian A. Lempp, Keith R. Jerome, Andrew B. Stuart, Joyce Y C Lu, Emily L Bossard, Bhanupriya Madarampalli, Margaret K. Doll, Jia Jin Kee, Kurt Diem, Lawrence Corey, Longping V. Tse, David C. Montefiori
Publikováno v:
Journal of Clinical Microbiology
Determinants of protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection require the development of well-standardized, reproducible antibody assays. This need has led to the emergence of a variety of neutrali
Autor:
Kurt Diem, Yixuan J. Hou, Emily S Ford, Leonidas Stamatatos, Peter B. Rupert, Anton M Sholukh, Roland K. Strong, Russell Saint Germain, Ralph S. Baric, Andrew B. Stuart, Chance Brock, Margaret K. Doll, April K. Randhawa, Matthew Buerger, Jia Jin Kee, Lawrence Corey, Keith R. Jerome, Andrew Fiore-Gartland, Hanna Kaiser, Florian A. Lempp, Emily L Bossard, Longping V. Tse, David C. Montefiori, Colleen McLaughlin
Publikováno v:
medRxiv
Determinants of protective immunity against SARS-CoV-2 infection require the development of well-standardized, reproducible antibody assays to be utilized in concert with clinical trials to establish correlates of risk and protection. This need has l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0657f8b73bf92be48fc49da6a215efdd
https://doi.org/10.1101/2020.12.07.20245431
https://doi.org/10.1101/2020.12.07.20245431